Fuxiang Pharmaceutical surged to the daily limit at market open, with estimated Q1 profits expected to skyrocket over 22 times!

Source: Securities Times Network Author: Yu Li

Today (March 24), major A-share indices opened higher but weakened, and by 10 a.m., all major indices turned red.

In the market, the pharmaceutical industry led the gains against the trend, with CRO concepts among the top performers. Fuxiang Pharmaceutical’s “20cm” stock hit the daily limit, Minohua also hit the limit, and Jin Kai Shengke, Bai Ao Saitu, and others rose over 8%.

Bank stocks mostly rose, with Jiangsu Bank, Nanjing Bank, and Shanghai Rural Commercial Bank up over 3%.

Two stocks surged after releasing their first-quarter earnings reports

Today, two companies announced their Q1 earnings forecasts. Fuxiang Pharmaceutical (300497) expects a profit of 52 million to 75 million yuan in Q1, a year-on-year increase of 2222.67%–3250.01%. The company stated that benefiting from the continued improvement in the new energy industry, steady growth in power battery market demand, and rapid explosion in energy storage battery market demand, upstream lithium battery materials demand has continued to rise. The company’s lithium battery electrolyte additive business is performing well, with core products like VC and FEC increasing in both volume and price, driving significant year-on-year growth in performance.

Yubo Xun expects a net profit of 38 million to 48 million yuan in Q1, a year-on-year increase of 79.23% to 126.4%.

In the early trading session today, both stocks opened significantly higher, with Fuxiang Pharmaceutical hitting the daily limit within the first minute of trading, and Yubo Xun once rising over 15%.

Two companies plan to raise funds through private placements

On March 24, two companies announced non-public offering plans.

Huazheng New Materials plans to issue no more than 47.0372 million shares to no more than 35 specific investors, aiming to raise 1.2 billion yuan mainly for the annual production of 12 million high-grade copper-clad laminate sheets and to supplement working capital.

Longtu Photomask plans to issue no more than 40.05 million shares to no more than 35 specific investors, aiming to raise 1.460 billion yuan mainly for the construction of a 40nm–28nm semiconductor mask production line.

The company stated that in China’s semiconductor mask industry, the high-end process fields of 40nm–28nm are still dominated by foreign manufacturers. Controlling the supply chain of optical masks independently is an inevitable choice to ensure the security of China’s semiconductor industry. With the implementation of this fundraising project, it can effectively fill the gap in the domestic high-end semiconductor mask market, break foreign monopolies, promote the coordinated development of China’s semiconductor industry chain, and accelerate the localization of semiconductor materials.

18 stocks received leverage funding exceeding 100 million yuan

As of March 23, the market financing balance was 2.6 trillion yuan, a decrease of 11.51 billion yuan from the previous trading day, marking three consecutive days of decline in financing balance.

Specifically, on March 23, 1,557 stocks received net financing inflows, with 385 stocks exceeding 10 million yuan in net buy-in. Among them, 18 stocks had net financing inflows over 100 million yuan. New Easy Sheng had the highest net buy-in at 805 million yuan; followed by Zhongji Xuchuang and Northern Rare Earth, with net inflows of 762 million yuan and 613 million yuan, respectively. Other stocks with high net buy-in included Aixu Shares, Longi Green Energy, and Mingyang Smart.